Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.036 CHF
−10.56 M CHF
1.62 M CHF
58.47 M
About ADDEX N
Sector
CEO
Timothy Dyer
Headquarters
Geneva
Website
Founded
2002
ISIN
CH0029850754
FIGI
BBG006M6ZCZ5
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APE is 0.081 CHF — it has decreased by −6.90% in the past 24 hours. Watch ADDEX THERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ADDEX THERAPEUTICS stocks are traded under the ticker APE.
We've gathered analysts' opinions on ADDEX THERAPEUTICS future price: according to them, APE price has a max estimate of 0.21 CHF and a min estimate of 0.21 CHF. Watch APE chart and read a more detailed ADDEX THERAPEUTICS stock forecast: see what analysts think of ADDEX THERAPEUTICS and suggest that you do with its stocks.
APE stock is 7.41% volatile and has beta coefficient of 0.60. Track ADDEX THERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is ADDEX THERAPEUTICS there?
Today ADDEX THERAPEUTICS has the market capitalization of 5.88 M, it has increased by 5.72% over the last week.
Yes, you can track ADDEX THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
ADDEX THERAPEUTICS is going to release the next earnings report on Nov 22, 2024. Keep track of upcoming events with our Earnings Calendar.
APE earnings for the last quarter are 0.08 CHF per share, whereas the estimation was −0.01 CHF resulting in a 900.00% surprise. The estimated earnings for the next quarter are −0.01 CHF per share. See more details about ADDEX THERAPEUTICS earnings.
ADDEX THERAPEUTICS revenue for the last quarter amounts to 115.00 K CHF, despite the estimated figure of 200.00 K CHF. In the next quarter, revenue is expected to reach 100.00 K CHF.
APE net income for the last quarter is 12.88 M CHF, while the quarter before that showed −3.09 M CHF of net income which accounts for 517.17% change. Track more ADDEX THERAPEUTICS financial stats to get the full picture.
No, APE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 23.00 employees. See our rating of the largest employees — is ADDEX THERAPEUTICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADDEX THERAPEUTICS EBITDA is −6.75 M CHF, and current EBITDA margin is −618.68%. See more stats in ADDEX THERAPEUTICS financial statements.
Like other stocks, APE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADDEX THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADDEX THERAPEUTICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADDEX THERAPEUTICS stock shows the sell signal. See more of ADDEX THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.